[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

2018-2023 Global Active Pharmaceutical Ingredients (API) Consumption Market Report

September 2018 | 176 pages | ID: 25C9E5B5E06EN
LP Information

US$ 4,660.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The report requires updating with new data and is sent in 48 hours after order is placed.

In this report, LP Information covers the present scenario (with the base year being 2017) and the growth prospects of global Active Pharmaceutical Ingredients (API) market for 2018-2023.

An active ingredient (AI) is the ingredient in a pharmaceutical drug that is biologically active. The similar terms active pharmaceutical ingredient (API) and bulk active are also used in medicine, and the term active substance may be used for natural products. Some medication products may contain more than one active ingredient. The traditional word for the API is pharmacon or pharmakon which originally denoted a magical substance or drug.
The EMEA average price of Active Pharmaceutical Ingredients is in the decreasing trend, from 6695 USD/MT in 2012 to 5483 USD/MT in 2017. With the situation of global economy, prices will be in decreasing trend in the following five years.
The classification of Active Pharmaceutical Ingredients includes synthetic APIs, biotech APIs, and the proportion of synthetic APIs in 2017 is about 85%, and the proportion is in decreasing trend from 2012 to 2017.
Active Pharmaceutical Ingredients is widely used in CNS, Cardiovascular, Genitourinary/Hormonal Drugs, Respiratory, Rheumatology, Diabetes, Oncology and other field. The most proportion of Active Pharmaceutical Ingredients is used for cardiovascular, and the proportion in 2017 is 21%.
Over the next five years, LPI(LP Information) projects that Active Pharmaceutical Ingredients (API) will register a xx% CAGR in terms of revenue, reach US$ xx million by 2023, from US$ xx million in 2017.

This report presents a comprehensive overview, market shares, and growth opportunities of Active Pharmaceutical Ingredients (API) market by product type, application, key manufacturers and key regions.

To calculate the market size, LP Information considers value and volume generated from the sales of the following segments:

Segmentation by product type:
  • Synthetic APIs
  • Biotech APIs
Segmentation by application:
  • CNS
  • Cardiovascular
  • Genitourinary/Hormonal Drugs
  • Respiratory
  • Rheumatology
  • Diabetes
  • Oncology
  • Others
This report also splits the market by region:
  • Americas
  • United States
  • Canada
  • Mexico
  • Brazil
  • APAC
  • China
  • Japan
  • Korea
  • Southeast Asia
  • India
  • Australia
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Russia
  • Spain
  • Middle East & Africa
  • Egypt
  • South Africa
  • Israel
  • Turkey
  • GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report:
  • Teva
  • Mylan
  • DSM
  • Aurobindo Pharma
  • Aspen
  • Novartis
  • BASF
  • Pfizer
  • Huahai Pharmaceutical
  • Hisun Pharmaceutical
  • Sun Pharmaceutical Industries
  • Zhejiang Medicine
  • Dr. Reddy’s Laboratories
  • Zhejiang NHU
  • Bayer
  • NCPC
  • AbbVie
  • Shandong Xinhua Pharmaceutical
  • Northeast Pharm
  • Harbin Pharmaceutical
  • LKPC
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
  • To study and analyze the global Active Pharmaceutical Ingredients (API) consumption (value & volume) by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2023.
  • To understand the structure of Active Pharmaceutical Ingredients (API) market by identifying its various subsegments.
  • Focuses on the key global Active Pharmaceutical Ingredients (API) manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
  • To analyze the Active Pharmaceutical Ingredients (API) with respect to individual growth trends, future prospects, and their contribution to the total market.
  • To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
  • To project the consumption of Active Pharmaceutical Ingredients (API) submarkets, with respect to key regions (along with their respective key countries).
  • To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
  • To strategically profile the key players and comprehensively analyze their growth strategies.
1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Active Pharmaceutical Ingredients (API) Consumption 2013-2023
  2.1.2 Active Pharmaceutical Ingredients (API) Consumption CAGR by Region
2.2 Active Pharmaceutical Ingredients (API) Segment by Type
  2.2.1 Synthetic APIs
  2.2.2 Biotech APIs
2.3 Active Pharmaceutical Ingredients (API) Consumption by Type
  2.3.1 Global Active Pharmaceutical Ingredients (API) Consumption Market Share by Type (2013-2018)
  2.3.2 Global Active Pharmaceutical Ingredients (API) Revenue and Market Share by Type (2013-2018)
  2.3.3 Global Active Pharmaceutical Ingredients (API) Sale Price by Type (2013-2018)
2.4 Active Pharmaceutical Ingredients (API) Segment by Application
  2.4.1 CNS
  2.4.2 Cardiovascular
  2.4.3 Genitourinary/Hormonal Drugs
  2.4.4 Respiratory
  2.4.5 Rheumatology
  2.4.6 Diabetes
  2.4.7 Oncology
  2.4.8 Others
2.5 Active Pharmaceutical Ingredients (API) Consumption by Application
  2.5.1 Global Active Pharmaceutical Ingredients (API) Consumption Market Share by Application (2013-2018)
  2.5.2 Global Active Pharmaceutical Ingredients (API) Value and Market Share by Application (2013-2018)
  2.5.3 Global Active Pharmaceutical Ingredients (API) Sale Price by Application (2013-2018)

3 GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS (API) BY PLAYERS

3.1 Global Active Pharmaceutical Ingredients (API) Sales Market Share by Players
  3.1.1 Global Active Pharmaceutical Ingredients (API) Sales by Players (2016-2018)
  3.1.2 Global Active Pharmaceutical Ingredients (API) Sales Market Share by Players (2016-2018)
3.2 Global Active Pharmaceutical Ingredients (API) Revenue Market Share by Players
  3.2.1 Global Active Pharmaceutical Ingredients (API) Revenue by Players (2016-2018)
  3.2.2 Global Active Pharmaceutical Ingredients (API) Revenue Market Share by Players (2016-2018)
3.3 Global Active Pharmaceutical Ingredients (API) Sale Price by Players
3.4 Global Active Pharmaceutical Ingredients (API) Manufacturing Base Distribution, Sales Area, Product Types by Players
  3.4.1 Global Active Pharmaceutical Ingredients (API) Manufacturing Base Distribution and Sales Area by Players
  3.4.2 Players Active Pharmaceutical Ingredients (API) Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 ACTIVE PHARMACEUTICAL INGREDIENTS (API) BY REGIONS

4.1 Active Pharmaceutical Ingredients (API) by Regions
  4.1.1 Global Active Pharmaceutical Ingredients (API) Consumption by Regions
  4.1.2 Global Active Pharmaceutical Ingredients (API) Value by Regions
4.2 Americas Active Pharmaceutical Ingredients (API) Consumption Growth
4.3 APAC Active Pharmaceutical Ingredients (API) Consumption Growth
4.4 Europe Active Pharmaceutical Ingredients (API) Consumption Growth
4.5 Middle East & Africa Active Pharmaceutical Ingredients (API) Consumption Growth

5 AMERICAS

5.1 Americas Active Pharmaceutical Ingredients (API) Consumption by Countries
  5.1.1 Americas Active Pharmaceutical Ingredients (API) Consumption by Countries (2013-2018)
  5.1.2 Americas Active Pharmaceutical Ingredients (API) Value by Countries (2013-2018)
5.2 Americas Active Pharmaceutical Ingredients (API) Consumption by Type
5.3 Americas Active Pharmaceutical Ingredients (API) Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries

6 APAC

6.1 APAC Active Pharmaceutical Ingredients (API) Consumption by Countries
  6.1.1 APAC Active Pharmaceutical Ingredients (API) Consumption by Countries (2013-2018)
  6.1.2 APAC Active Pharmaceutical Ingredients (API) Value by Countries (2013-2018)
6.2 APAC Active Pharmaceutical Ingredients (API) Consumption by Type
6.3 APAC Active Pharmaceutical Ingredients (API) Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries

7 EUROPE

7.1 Europe Active Pharmaceutical Ingredients (API) by Countries
  7.1.1 Europe Active Pharmaceutical Ingredients (API) Consumption by Countries (2013-2018)
  7.1.2 Europe Active Pharmaceutical Ingredients (API) Value by Countries (2013-2018)
7.2 Europe Active Pharmaceutical Ingredients (API) Consumption by Type
7.3 Europe Active Pharmaceutical Ingredients (API) Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Active Pharmaceutical Ingredients (API) by Countries
  8.1.1 Middle East & Africa Active Pharmaceutical Ingredients (API) Consumption by Countries (2013-2018)
  8.1.2 Middle East & Africa Active Pharmaceutical Ingredients (API) Value by Countries (2013-2018)
8.2 Middle East & Africa Active Pharmaceutical Ingredients (API) Consumption by Type
8.3 Middle East & Africa Active Pharmaceutical Ingredients (API) Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers and Impact
  9.1.1 Growing Demand from Key Regions
  9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 MARKETING, DISTRIBUTORS AND CUSTOMER

10.1 Sales Channel
  10.1.1 Direct Marketing
  10.1.2 Indirect Marketing
10.2 Active Pharmaceutical Ingredients (API) Distributors
10.3 Active Pharmaceutical Ingredients (API) Customer

11 GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS (API) MARKET FORECAST

11.1 Global Active Pharmaceutical Ingredients (API) Consumption Forecast (2018-2023)
11.2 Global Active Pharmaceutical Ingredients (API) Forecast by Regions
  11.2.1 Global Active Pharmaceutical Ingredients (API) Forecast by Regions (2018-2023)
  11.2.2 Global Active Pharmaceutical Ingredients (API) Value Forecast by Regions (2018-2023)
  11.2.3 Americas Consumption Forecast
  11.2.4 APAC Consumption Forecast
  11.2.5 Europe Consumption Forecast
  11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
  11.3.1 United States Market Forecast
  11.3.2 Canada Market Forecast
  11.3.3 Mexico Market Forecast
  11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
  11.4.1 China Market Forecast
  11.4.2 Japan Market Forecast
  11.4.3 Korea Market Forecast
  11.4.4 Southeast Asia Market Forecast
  11.4.5 India Market Forecast
  11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
  11.5.1 Germany Market Forecast
  11.5.2 France Market Forecast
  11.5.3 UK Market Forecast
  11.5.4 Italy Market Forecast
  11.5.5 Russia Market Forecast
  11.5.6 Spain Market Forecast
11.6 Middle East & Africa Forecast by Countries
  11.6.1 Egypt Market Forecast
  11.6.2 South Africa Market Forecast
  11.6.3 Israel Market Forecast
  11.6.4 Turkey Market Forecast
  11.6.5 GCC Countries Market Forecast
11.7 Global Active Pharmaceutical Ingredients (API) Forecast by Type
11.8 Global Active Pharmaceutical Ingredients (API) Forecast by Application

12 KEY PLAYERS ANALYSIS

12.1 Teva
  12.1.1 Company Details
  12.1.2 Active Pharmaceutical Ingredients (API) Product Offered
  12.1.3 Teva Active Pharmaceutical Ingredients (API) Sales, Revenue, Price and Gross Margin (2016-2018)
  12.1.4 Main Business Overview
  12.1.5 Teva News
12.2 Mylan
  12.2.1 Company Details
  12.2.2 Active Pharmaceutical Ingredients (API) Product Offered
  12.2.3 Mylan Active Pharmaceutical Ingredients (API) Sales, Revenue, Price and Gross Margin (2016-2018)
  12.2.4 Main Business Overview
  12.2.5 Mylan News
12.3 DSM
  12.3.1 Company Details
  12.3.2 Active Pharmaceutical Ingredients (API) Product Offered
  12.3.3 DSM Active Pharmaceutical Ingredients (API) Sales, Revenue, Price and Gross Margin (2016-2018)
  12.3.4 Main Business Overview
  12.3.5 DSM News
12.4 Aurobindo Pharma
  12.4.1 Company Details
  12.4.2 Active Pharmaceutical Ingredients (API) Product Offered
  12.4.3 Aurobindo Pharma Active Pharmaceutical Ingredients (API) Sales, Revenue, Price and Gross Margin (2016-2018)
  12.4.4 Main Business Overview
  12.4.5 Aurobindo Pharma News
12.5 Aspen
  12.5.1 Company Details
  12.5.2 Active Pharmaceutical Ingredients (API) Product Offered
  12.5.3 Aspen Active Pharmaceutical Ingredients (API) Sales, Revenue, Price and Gross Margin (2016-2018)
  12.5.4 Main Business Overview
  12.5.5 Aspen News
12.6 Novartis
  12.6.1 Company Details
  12.6.2 Active Pharmaceutical Ingredients (API) Product Offered
  12.6.3 Novartis Active Pharmaceutical Ingredients (API) Sales, Revenue, Price and Gross Margin (2016-2018)
  12.6.4 Main Business Overview
  12.6.5 Novartis News
12.7 BASF
  12.7.1 Company Details
  12.7.2 Active Pharmaceutical Ingredients (API) Product Offered
  12.7.3 BASF Active Pharmaceutical Ingredients (API) Sales, Revenue, Price and Gross Margin (2016-2018)
  12.7.4 Main Business Overview
  12.7.5 BASF News
12.8 Pfizer
  12.8.1 Company Details
  12.8.2 Active Pharmaceutical Ingredients (API) Product Offered
  12.8.3 Pfizer Active Pharmaceutical Ingredients (API) Sales, Revenue, Price and Gross Margin (2016-2018)
  12.8.4 Main Business Overview
  12.8.5 Pfizer News
12.9 Huahai Pharmaceutical
  12.9.1 Company Details
  12.9.2 Active Pharmaceutical Ingredients (API) Product Offered
  12.9.3 Huahai Pharmaceutical Active Pharmaceutical Ingredients (API) Sales, Revenue, Price and Gross Margin (2016-2018)
  12.9.4 Main Business Overview
  12.9.5 Huahai Pharmaceutical News
12.10 Hisun Pharmaceutical
  12.10.1 Company Details
  12.10.2 Active Pharmaceutical Ingredients (API) Product Offered
  12.10.3 Hisun Pharmaceutical Active Pharmaceutical Ingredients (API) Sales, Revenue, Price and Gross Margin (2016-2018)
  12.10.4 Main Business Overview
  12.10.5 Hisun Pharmaceutical News
12.11 Sun Pharmaceutical Industries
12.12 Zhejiang Medicine
12.13 Dr. Reddy’s Laboratories
12.14 Zhejiang NHU
12.15 Bayer
12.16 NCPC
12.17 AbbVie
12.18 Shandong Xinhua Pharmaceutical
12.19 Northeast Pharm
12.20 Harbin Pharmaceutical
12.21 LKPC

13 RESEARCH FINDINGS AND CONCLUSION

LIST OF TABLES AND FIGURES

Figure Picture of Active Pharmaceutical Ingredients (API)
Table Product Specifications of Active Pharmaceutical Ingredients (API)
Figure Active Pharmaceutical Ingredients (API) Report Years Considered
Figure Market Research Methodology
Figure Global Active Pharmaceutical Ingredients (API) Consumption Growth Rate 2013-2023 (K MT)
Figure Global Active Pharmaceutical Ingredients (API) Value Growth Rate 2013-2023 ($ Millions)
Table Active Pharmaceutical Ingredients (API) Consumption CAGR by Region 2013-2023 ($ Millions)
Figure Product Picture of Synthetic APIs
Table Major Players of Synthetic APIs
Figure Product Picture of Biotech APIs
Table Major Players of Biotech APIs
Table Global Consumption Sales by Type (2013-2018)
Table Global Active Pharmaceutical Ingredients (API) Consumption Market Share by Type (2013-2018)
Figure Global Active Pharmaceutical Ingredients (API) Consumption Market Share by Type (2013-2018)
Table Global Active Pharmaceutical Ingredients (API) Revenue by Type (2013-2018) ($ million)
Table Global Active Pharmaceutical Ingredients (API) Value Market Share by Type (2013-2018) ($ Millions)
Figure Global Active Pharmaceutical Ingredients (API) Value Market Share by Type (2013-2018)
Table Global Active Pharmaceutical Ingredients (API) Sale Price by Type (2013-2018)
Figure Active Pharmaceutical Ingredients (API) Consumed in CNS
Figure Global Active Pharmaceutical Ingredients (API) Market: CNS (2013-2018) (K MT)
Figure Global Active Pharmaceutical Ingredients (API) Market: CNS (2013-2018) ($ Millions)
Figure Global CNS YoY Growth ($ Millions)
Figure Active Pharmaceutical Ingredients (API) Consumed in Cardiovascular
Figure Global Active Pharmaceutical Ingredients (API) Market: Cardiovascular (2013-2018) (K MT)
Figure Global Active Pharmaceutical Ingredients (API) Market: Cardiovascular (2013-2018) ($ Millions)
Figure Global Cardiovascular YoY Growth ($ Millions)
Figure Active Pharmaceutical Ingredients (API) Consumed in Genitourinary/Hormonal Drugs
Figure Global Active Pharmaceutical Ingredients (API) Market: Genitourinary/Hormonal Drugs (2013-2018) (K MT)
Figure Global Active Pharmaceutical Ingredients (API) Market: Genitourinary/Hormonal Drugs (2013-2018) ($ Millions)
Figure Global Genitourinary/Hormonal Drugs YoY Growth ($ Millions)
Figure Active Pharmaceutical Ingredients (API) Consumed in Respiratory
Figure Global Active Pharmaceutical Ingredients (API) Market: Respiratory (2013-2018) (K MT)
Figure Global Active Pharmaceutical Ingredients (API) Market: Respiratory (2013-2018) ($ Millions)
Figure Global Respiratory YoY Growth ($ Millions)
Figure Active Pharmaceutical Ingredients (API) Consumed in Rheumatology
Figure Global Active Pharmaceutical Ingredients (API) Market: Rheumatology (2013-2018) (K MT)
Figure Global Active Pharmaceutical Ingredients (API) Market: Rheumatology (2013-2018) ($ Millions)
Figure Global Rheumatology YoY Growth ($ Millions)
Figure Active Pharmaceutical Ingredients (API) Consumed in Diabetes
Figure Active Pharmaceutical Ingredients (API) Consumed in Oncology
Figure Active Pharmaceutical Ingredients (API) Consumed in Others
Table Global Consumption Sales by Application (2013-2018)
Table Global Active Pharmaceutical Ingredients (API) Consumption Market Share by Application (2013-2018)
Figure Global Active Pharmaceutical Ingredients (API) Consumption Market Share by Application (2013-2018)
Table Global Active Pharmaceutical Ingredients (API) Value by Application (2013-2018)
Table Global Active Pharmaceutical Ingredients (API) Value Market Share by Application (2013-2018)
Figure Global Active Pharmaceutical Ingredients (API) Value Market Share by Application (2013-2018)
Table Global Active Pharmaceutical Ingredients (API) Sale Price by Application (2013-2018)
Table Global Active Pharmaceutical Ingredients (API) Sales by Players (2016-2018) (K MT)
Table Global Active Pharmaceutical Ingredients (API) Sales Market Share by Players (2016-2018)
Figure Global Active Pharmaceutical Ingredients (API) Sales Market Share by Players in 2016
Figure Global Active Pharmaceutical Ingredients (API) Sales Market Share by Players in 2017
Table Global Active Pharmaceutical Ingredients (API) Revenue by Players (2016-2018) ($ Millions)
Table Global Active Pharmaceutical Ingredients (API) Revenue Market Share by Players (2016-2018)
Figure Global Active Pharmaceutical Ingredients (API) Revenue Market Share by Players in 2016
Figure Global Active Pharmaceutical Ingredients (API) Revenue Market Share by Players in 2017
Table Global Active Pharmaceutical Ingredients (API) Sale Price by Players (2016-2018)
Figure Global Active Pharmaceutical Ingredients (API) Sale Price by Players in 2017
Table Global Active Pharmaceutical Ingredients (API) Manufacturing Base Distribution and Sales Area by Players
Table Players Active Pharmaceutical Ingredients (API) Products Offered
Table Active Pharmaceutical Ingredients (API) Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
Table Global Active Pharmaceutical Ingredients (API) Consumption by Regions 2013-2018 (K MT)
Table Global Active Pharmaceutical Ingredients (API) Consumption Market Share by Regions 2013-2018
Figure Global Active Pharmaceutical Ingredients (API) Consumption Market Share by Regions 2013-2018
Table Global Active Pharmaceutical Ingredients (API) Value by Regions 2013-2018 ($ Millions)
Table Global Active Pharmaceutical Ingredients (API) Value Market Share by Regions 2013-2018
Figure Global Active Pharmaceutical Ingredients (API) Value Market Share by Regions 2013-2018
Figure Americas Active Pharmaceutical Ingredients (API) Consumption 2013-2018 (K MT)
Figure Americas Active Pharmaceutical Ingredients (API) Value 2013-2018 ($ Millions)
Figure APAC Active Pharmaceutical Ingredients (API) Consumption 2013-2018 (K MT)
Figure APAC Active Pharmaceutical Ingredients (API) Value 2013-2018 ($ Millions)
Figure Europe Active Pharmaceutical Ingredients (API) Consumption 2013-2018 (K MT)
Figure Europe Active Pharmaceutical Ingredients (API) Value 2013-2018 ($ Millions)
Figure Middle East & Africa Active Pharmaceutical Ingredients (API) Consumption 2013-2018 (K MT)
Figure Middle East & Africa Active Pharmaceutical Ingredients (API) Value 2013-2018 ($ Millions)
Table Americas Active Pharmaceutical Ingredients (API) Consumption by Countries (2013-2018) (K MT)
Table Americas Active Pharmaceutical Ingredients (API) Consumption Market Share by Countries (2013-2018)
Figure Americas Active Pharmaceutical Ingredients (API) Consumption Market Share by Countries in 2017
Table Americas Active Pharmaceutical Ingredients (API) Value by Countries (2013-2018) ($ Millions)
Table Americas Active Pharmaceutical Ingredients (API) Value Market Share by Countries (2013-2018)
Figure Americas Active Pharmaceutical Ingredients (API) Value Market Share by Countries in 2017
Table Americas Active Pharmaceutical Ingredients (API) Consumption by Type (2013-2018) (K MT)
Table Americas Active Pharmaceutical Ingredients (API) Consumption Market Share by Type (2013-2018)
Figure Americas Active Pharmaceutical Ingredients (API) Consumption Market Share by Type in 2017
Table Americas Active Pharmaceutical Ingredients (API) Consumption by Application (2013-2018) (K MT)
Table Americas Active Pharmaceutical Ingredients (API) Consumption Market Share by Application (2013-2018)
Figure Americas Active Pharmaceutical Ingredients (API) Consumption Market Share by Application in 2017
Figure United States Active Pharmaceutical Ingredients (API) Consumption Growth 2013-2018 (K MT)
Figure United States Active Pharmaceutical Ingredients (API) Value Growth 2013-2018 ($ Millions)
Figure Canada Active Pharmaceutical Ingredients (API) Consumption Growth 2013-2018 (K MT)
Figure Canada Active Pharmaceutical Ingredients (API) Value Growth 2013-2018 ($ Millions)
Figure Mexico Active Pharmaceutical Ingredients (API) Consumption Growth 2013-2018 (K MT)
Figure Mexico Active Pharmaceutical Ingredients (API) Value Growth 2013-2018 ($ Millions)
Table APAC Active Pharmaceutical Ingredients (API) Consumption by Countries (2013-2018) (K MT)
Table APAC Active Pharmaceutical Ingredients (API) Consumption Market Share by Countries (2013-2018)
Figure APAC Active Pharmaceutical Ingredients (API) Consumption Market Share by Countries in 2017
Table APAC Active Pharmaceutical Ingredients (API) Value by Countries (2013-2018) ($ Millions)
Table APAC Active Pharmaceutical Ingredients (API) Value Market Share by Countries (2013-2018)
Figure APAC Active Pharmaceutical Ingredients (API) Value Market Share by Countries in 2017
Table APAC Active Pharmaceutical Ingredients (API) Consumption by Type (2013-2018) (K MT)
Table APAC Active Pharmaceutical Ingredients (API) Consumption Market Share by Type (2013-2018)
Figure APAC Active Pharmaceutical Ingredients (API) Consumption Market Share by Type in 2017
Table APAC Active Pharmaceutical Ingredients (API) Consumption by Application (2013-2018) (K MT)
Table APAC Active Pharmaceutical Ingredients (API) Consumption Market Share by Application (2013-2018)
Figure APAC Active Pharmaceutical Ingredients (API) Consumption Market Share by Application in 2017
Figure China Active Pharmaceutical Ingredients (API) Consumption Growth 2013-2018 (K MT)
Figure China Active Pharmaceutical Ingredients (API) Value Growth 2013-2018 ($ Millions)
Figure Japan Active Pharmaceutical Ingredients (API) Consumption Growth 2013-2018 (K MT)
Figure Japan Active Pharmaceutical Ingredients (API) Value Growth 2013-2018 ($ Millions)
Figure Korea Active Pharmaceutical Ingredients (API) Consumption Growth 2013-2018 (K MT)
Figure Korea Active Pharmaceutical Ingredients (API) Value Growth 2013-2018 ($ Millions)
Figure Southeast Asia Active Pharmaceutical Ingredients (API) Consumption Growth 2013-2018 (K MT)
Figure Southeast Asia Active Pharmaceutical Ingredients (API) Value Growth 2013-2018 ($ Millions)
Figure India Active Pharmaceutical Ingredients (API) Consumption Growth 2013-2018 (K MT)
Figure India Active Pharmaceutical Ingredients (API) Value Growth 2013-2018 ($ Millions)
Figure Australia Active Pharmaceutical Ingredients (API) Consumption Growth 2013-2018 (K MT)
Figure Australia Active Pharmaceutical Ingredients (API) Value Growth 2013-2018 ($ Millions)
Table Europe Active Pharmaceutical Ingredients (API) Consumption by Countries (2013-2018) (K MT)
Table Europe Active Pharmaceutical Ingredients (API) Consumption Market Share by Countries (2013-2018)
Figure Europe Active Pharmaceutical Ingredients (API) Consumption Market Share by Countries in 2017
Table Europe Active Pharmaceutical Ingredients (API) Value by Countries (2013-2018) ($ Millions)
Table Europe Active Pharmaceutical Ingredients (API) Value Market Share by Countries (2013-2018)
Figure Europe Active Pharmaceutical Ingredients (API) Value Market Share by Countries in 2017
Table Europe Active Pharmaceutical Ingredients (API) Consumption by Type (2013-2018) (K MT)
Table Europe Active Pharmaceutical Ingredients (API) Consumption Market Share by Type (2013-2018)
Figure Europe Active Pharmaceutical Ingredients (API) Consumption Market Share by Type in 2017
Table Europe Active Pharmaceutical Ingredients (API) Consumption by Application (2013-2018) (K MT)
Table Europe Active Pharmaceutical Ingredients (API) Consumption Market Share by Application (2013-2018)
Figure Europe Active Pharmaceutical Ingredients (API) Consumption Market Share by Application in 2017
Figure Germany Active Pharmaceutical Ingredients (API) Consumption Growth 2013-2018 (K MT)
Figure Germany Active Pharmaceutical Ingredients (API) Value Growth 2013-2018 ($ Millions)
Figure France Active Pharmaceutical Ingredients (API) Consumption Growth 2013-2018 (K MT)
Figure France Active Pharmaceutical Ingredients (API) Value Growth 2013-2018 ($ Millions)
Figure UK Active Pharmaceutical Ingredients (API) Consumption Growth 2013-2018 (K MT)
Figure UK Active Pharmaceutical Ingredients (API) Value Growth 2013-2018 ($ Millions)
Figure Italy Active Pharmaceutical Ingredients (API) Consumption Growth 2013-2018 (K MT)
Figure Italy Active Pharmaceutical Ingredients (API) Value Growth 2013-2018 ($ Millions)
Figure Russia Active Pharmaceutical Ingredients (API) Consumption Growth 2013-2018 (K MT)
Figure Russia Active Pharmaceutical Ingredients (API) Value Growth 2013-2018 ($ Millions)
Figure Spain Active Pharmaceutical Ingredients (API) Consumption Growth 2013-2018 (K MT)
Figure Spain Active Pharmaceutical Ingredients (API) Value Growth 2013-2018 ($ Millions)
Table Middle East & Africa Active Pharmaceutical Ingredients (API) Consumption by Countries (2013-2018) (K MT)
Table Middle East & Africa Active Pharmaceutical Ingredients (API) Consumption Market Share by Countries (2013-2018)
Figure Middle East & Africa Active Pharmaceutical Ingredients (API) Consumption Market Share by Countries in 2017
Table Middle East & Africa Active Pharmaceutical Ingredients (API) Value by Countries (2013-2018) ($ Millions)
Table Middle East & Africa Active Pharmaceutical Ingredients (API) Value Market Share by Countries (2013-2018)
Figure Middle East & Africa Active Pharmaceutical Ingredients (API) Value Market Share by Countries in 2017
Table Middle East & Africa Active Pharmaceutical Ingredients (API) Consumption by Type (2013-2018) (K MT)
Table Middle East & Africa Active Pharmaceutical Ingredients (API) Consumption Market Share by Type (2013-2018)
Figure Middle East & Africa Active Pharmaceutical Ingredients (API) Consumption Market Share by Type in 2017
Table Middle East & Africa Active Pharmaceutical Ingredients (API) Consumption by Application (2013-2018) (K MT)
Table Middle East & Africa Active Pharmaceutical Ingredients (API) Consumption Market Share by Application (2013-2018)
Figure Middle East & Africa Active Pharmaceutical Ingredients (API) Consumption Market Share by Application in 2017
Figure Egypt Active Pharmaceutical Ingredients (API) Consumption Growth 2013-2018 (K MT)
Figure Egypt Active Pharmaceutical Ingredients (API) Value Growth 2013-2018 ($ Millions)
Figure South Africa Active Pharmaceutical Ingredients (API) Consumption Growth 2013-2018 (K MT)
Figure South Africa Active Pharmaceutical Ingredients (API) Value Growth 2013-2018 ($ Millions)
Figure Israel Active Pharmaceutical Ingredients (API) Consumption Growth 2013-2018 (K MT)
Figure Israel Active Pharmaceutical Ingredients (API) Value Growth 2013-2018 ($ Millions)
Figure Turkey Active Pharmaceutical Ingredients (API) Consumption Growth 2013-2018 (K MT)
Figure Turkey Active Pharmaceutical Ingredients (API) Value Growth 2013-2018 ($ Millions)
Figure GCC Countries Active Pharmaceutical Ingredients (API) Consumption Growth 2013-2018 (K MT)
Figure GCC Countries Active Pharmaceutical Ingredients (API) Value Growth 2013-2018 ($ Millions)
Table Active Pharmaceutical Ingredients (API) Distributors List
Table Active Pharmaceutical Ingredients (API) Customer List
Figure Global Active Pharmaceutical Ingredients (API) Consumption Growth Rate Forecast (2018-2023) (K MT)
Figure Global Active Pharmaceutical Ingredients (API) Value Growth Rate Forecast (2018-2023) ($ Millions)
Table Global Active Pharmaceutical Ingredients (API) Consumption Forecast by Countries (2018-2023) (K MT)
Table Global Active Pharmaceutical Ingredients (API) Consumption Market Forecast by Regions
Table Global Active Pharmaceutical Ingredients (API) Value Forecast by Countries (2018-2023) ($ Millions)
Table Global Active Pharmaceutical Ingredients (API) Value Market Share Forecast by Regions
Figure Americas Active Pharmaceutical Ingredients (API) Consumption 2018-2023 (K MT)
Figure Americas Active Pharmaceutical Ingredients (API) Value 2018-2023 ($ Millions)
Figure APAC Active Pharmaceutical Ingredients (API) Consumption 2018-2023 (K MT)
Figure APAC Active Pharmaceutical Ingredients (API) Value 2018-2023 ($ Millions)
Figure Europe Active Pharmaceutical Ingredients (API) Consumption 2018-2023 (K MT)
Figure Europe Active Pharmaceutical Ingredients (API) Value 2018-2023 ($ Millions)
Figure Middle East & Africa Active Pharmaceutical Ingredients (API) Consumption 2018-2023 (K MT)
Figure Middle East & Africa Active Pharmaceutical Ingredients (API) Value 2018-2023 ($ Millions)
Figure United States Active Pharmaceutical Ingredients (API) Consumption 2018-2023 (K MT)
Figure United States Active Pharmaceutical Ingredients (API) Value 2018-2023 ($ Millions)
Figure Canada Active Pharmaceutical Ingredients (API) Consumption 2018-2023 (K MT)
Figure Canada Active Pharmaceutical Ingredients (API) Value 2018-2023 ($ Millions)
Figure Mexico Active Pharmaceutical Ingredients (API) Consumption 2018-2023 (K MT)
Figure Mexico Active Pharmaceutical Ingredients (API) Value 2018-2023 ($ Millions)
Figure Brazil Active Pharmaceutical Ingredients (API) Consumption 2018-2023 (K MT)
Figure Brazil Active Pharmaceutical Ingredients (API) Value 2018-2023 ($ Millions)
Figure China Active Pharmaceutical Ingredients (API) Consumption 2018-2023 (K MT)
Figure China Active Pharmaceutical Ingredients (API) Value 2018-2023 ($ Millions)
Figure Japan Active Pharmaceutical Ingredients (API) Consumption 2018-2023 (K MT)
Figure Japan Active Pharmaceutical Ingredients (API) Value 2018-2023 ($ Millions)
Figure Korea Active Pharmaceutical Ingredients (API) Consumption 2018-2023 (K MT)
Figure Korea Active Pharmaceutical Ingredients (API) Value 2018-2023 ($ Millions)
Figure Southeast Asia Active Pharmaceutical Ingredients (API) Consumption 2018-2023 (K MT)
Figure Southeast Asia Active Pharmaceutical Ingredients (API) Value 2018-2023 ($ Millions)
Figure India Active Pharmaceutical Ingredients (API) Consumption 2018-2023 (K MT)
Figure India Active Pharmaceutical Ingredients (API) Value 2018-2023 ($ Millions)
Figure Australia Active Pharmaceutical Ingredients (API) Consumption 2018-2023 (K MT)
Figure Australia Active Pharmaceutical Ingredients (API) Value 2018-2023 ($ Millions)
Figure Germany Active Pharmaceutical Ingredients (API) Consumption 2018-2023 (K MT)
Figure Germany Active Pharmaceutical Ingredients (API) Value 2018-2023 ($ Millions)
Figure France Active Pharmaceutical Ingredients (API) Consumption 2018-2023 (K MT)
Figure France Active Pharmaceutical Ingredients (API) Value 2018-2023 ($ Millions)
Figure UK Active Pharmaceutical Ingredients (API) Consumption 2018-2023 (K MT)
Figure UK Active Pharmaceutical Ingredients (API) Value 2018-2023 ($ Millions)
Figure Italy Active Pharmaceutical Ingredients (API) Consumption 2018-2023 (K MT)
Figure Italy Active Pharmaceutical Ingredients (API) Value 2018-2023 ($ Millions)
Figure Russia Active Pharmaceutical Ingredients (API) Consumption 2018-2023 (K MT)
Figure Russia Active Pharmaceutical Ingredients (API) Value 2018-2023 ($ Millions)
Figure Spain Active Pharmaceutical Ingredients (API) Consumption 2018-2023 (K MT)
Figure Spain Active Pharmaceutical Ingredients (API) Value 2018-2023 ($ Millions)
Figure Egypt Active Pharmaceutical Ingredients (API) Consumption 2018-2023 (K MT)
Figure Egypt Active Pharmaceutical Ingredients (API) Value 2018-2023 ($ Millions)
Figure South Africa Active Pharmaceutical Ingredients (API) Consumption 2018-2023 (K MT)
Figure South Africa Active Pharmaceutical Ingredients (API) Value 2018-2023 ($ Millions)
Figure Israel Active Pharmaceutical Ingredients (API) Consumption 2018-2023 (K MT)
Figure Israel Active Pharmaceutical Ingredients (API) Value 2018-2023 ($ Millions)
Figure Turkey Active Pharmaceutical Ingredients (API) Consumption 2018-2023 (K MT)
Figure Turkey Active Pharmaceutical Ingredients (API) Value 2018-2023 ($ Millions)
Figure GCC Countries Active Pharmaceutical Ingredients (API) Consumption 2018-2023 (K MT)
Figure GCC Countries Active Pharmaceutical Ingredients (API) Value 2018-2023 ($ Millions)
Table Global Active Pharmaceutical Ingredients (API) Consumption Forecast by Type (2018-2023) (K MT)
Table Global Active Pharmaceutical Ingredients (API) Consumption Market Share Forecast by Type (2018-2023)
Table Global Active Pharmaceutical Ingredients (API) Value Forecast by Type (2018-2023) ($ Millions)
Table Global Active Pharmaceutical Ingredients (API) Value Market Share Forecast by Type (2018-2023)
Table Global Active Pharmaceutical Ingredients (API) Consumption Forecast by Application (2018-2023) (K MT)
Table Global Active Pharmaceutical Ingredients (API) Consumption Market Share Forecast by Application (2018-2023)
Table Global Active Pharmaceutical Ingredients (API) Value Forecast by Application (2018-2023) ($ Millions)
Table Global Active Pharmaceutical Ingredients (API) Value Market Share Forecast by Application (2018-2023)
Table Teva Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Teva Active Pharmaceutical Ingredients (API) Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Teva Active Pharmaceutical Ingredients (API) Market Share (2016-2018)
Table Mylan Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Mylan Active Pharmaceutical Ingredients (API) Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Mylan Active Pharmaceutical Ingredients (API) Market Share (2016-2018)
Table DSM Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table DSM Active Pharmaceutical Ingredients (API) Sales, Revenue, Price and Gross Margin (2016-2018)
Figure DSM Active Pharmaceutical Ingredients (API) Market Share (2016-2018)
Table Aurobindo Pharma Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Aurobindo Pharma Active Pharmaceutical Ingredients (API) Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Aurobindo Pharma Active Pharmaceutical Ingredients (API) Market Share (2016-2018)
Table Aspen Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Aspen Active Pharmaceutical Ingredients (API) Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Aspen Active Pharmaceutical Ingredients (API) Market Share (2016-2018)
Table Novartis Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Novartis Active Pharmaceutical Ingredients (API) Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Novartis Active Pharmaceutical Ingredients (API) Market Share (2016-2018)
Table BASF Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table BASF Active Pharmaceutical Ingredients (API) Sales, Revenue, Price and Gross Margin (2016-2018)
Figure BASF Active Pharmaceutical Ingredients (API) Market Share (2016-2018)
Table Pfizer Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Pfizer Active Pharmaceutical Ingredients (API) Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Pfizer Active Pharmaceutical Ingredients (API) Market Share (2016-2018)
Table Huahai Pharmaceutical Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Huahai Pharmaceutical Active Pharmaceutical Ingredients (API) Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Huahai Pharmaceutical Active Pharmaceutical Ingredients (API) Market Share (2016-2018)
Table Hisun Pharmaceutical Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Hisun Pharmaceutical Active Pharmaceutical Ingredients (API) Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Hisun Pharmaceutical Active Pharmaceutical Ingredients (API) Market Share (2016-2018)
Table Sun Pharmaceutical Industries Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Zhejiang Medicine Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Dr. Reddy’s Laboratories Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Zhejiang NHU Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Bayer Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table NCPC Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table AbbVie Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Shandong Xinhua Pharmaceutical Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Northeast Pharm Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Harbin Pharmaceutical Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table LKPC Basic Information, Manufacturing Base, Sales Area and Its Competitors


More Publications